Loading...

Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients

BACKGROUND: Several reports suggest that vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma (mRCC) may be more toxic in Asian vs non-Asian populations. Comparative efficacy of these agents with respect to ethnicity is not well characterised. METHODS: A mult...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Wang, Y, Choueiri, T K, Lee, J-L, Tan, M-H, Rha, S Y, North, S A, Kollmannsberger, C K, McDermott, D F, Heng, D Y C
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3960609/
https://ncbi.nlm.nih.gov/pubmed/24548864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.28
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!